Health Affairs, 27, no. 1 (2008): 33-43 doi: 10.1377/hlthaff.27.1.33 © 2008 by Project HOPE	New Online   New Issue: China & India   Obesity In China   Pay Cuts For Medicare Docs   Access To Care Woes

This Article Figures Only Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Frank, R. G. Articles by Newhouse, J. P. Search for Related Content PubMed PubMed Citation Articles by Frank, R. G. Articles by Newhouse, J. P. Related Collections Insurance Market Business Of Health Consumer Issues Health Reform Managed Care - Consumers Managed Care - Medicare Medicare Pharmaceuticals

Medicare

Should Drug Prices Be Negotiated Under Part D Of Medicare? And If So, How?

Medicare’s Part D prescription drug benefit has offered affordable coverage to millions of elderly Americans since its January 2006 implementation. A great deal of concern has been expressed about whether drugs are being purchased in a cost-effective manner. Many believe that the government should be negotiating prices with pharmaceutical manufacturers. We look at prescription drug pricing under Part D by examining the logic behind existing arrangements and by reviewing initial evidence on the behavior of prices. We make a modest proposal for how to improve purchasing of prescription drugs in Medicare.

                      What's this?